Search research articles
Contact Us
Filters
Showing results (1081-1090 of 1,278) with videos related to
Page
of 128
Sort By:
Biorxiv : the Preprint Server for Biology
|
June 5, 2026
Substrate and target selectivity of 4'-fluoroadenosine against viral and host polymerases
Simon M Walker, Arlo J Loutan, Egor P Tchesnokov, et al.
The Journal of Biological Chemistry
|
July 6, 2026
Substrate and target selectivity of 4'-fluoroadenosine against viral and host polymerases
Simon M Walker, Arlo J Loutan, Egor P Tchesnokov, et al.
Journal of Bacteriology
|
September 15, 2005
Whole-genome sequence analysis of Pseudomonas syringae pv. phaseolicola 1448A reveals divergence among pathovars in genes involved in virulence and transposition
Vinita Joardar, Magdalen Lindeberg, Robert W Jackson, et al.
Nature Chemical Biology
|
September 29, 2022
Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infection
Chang-Ki Oh, Tomohiro Nakamura, Nathan Beutler, et al.
Oncogenesis
|
May 10, 2016
Association of p53 codon72 Arg>Pro polymorphism with susceptibility to nasopharyngeal carcinoma: evidence from a case-control study and meta-analysis
S K Sahu, S Chakrabarti, S D Roy, et al.
Nature Communications
|
February 8, 2024
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor
Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak, et al.
Biorxiv : the Preprint Server for Biology
|
April 12, 2022
Targeted protein S-nitrosylation of ACE2 as potential treatment to prevent spread of SARS-CoV-2 infection
Chang-Ki Oh, Tomohiro Nakamura, Nathan Beutler, et al.
ACS Medicinal Chemistry Letters
|
August 23, 2014
Lead optimization of imidazopyrazines: a new class of antimalarial with activity on Plasmodium liver stages
Bin Zou, Advait Nagle, Arnab K Chatterjee, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals
Laura Riva, Shuofeng Yuan, Xin Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2020
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer
Preeti Narayan, Tatiana M Prowell, Jennifer J Gao, et al.
Page
of 128
Search research articles
Search
Showing results (1081-1090 of 1,278) with videos related to
Sort By:
Page
of 128
Biorxiv : the Preprint Server for Biology
|
June 5, 2026
Substrate and target selectivity of 4'-fluoroadenosine against viral and host polymerases
Simon M Walker, Arlo J Loutan, Egor P Tchesnokov, et al.
The Journal of Biological Chemistry
|
July 6, 2026
Substrate and target selectivity of 4'-fluoroadenosine against viral and host polymerases
Simon M Walker, Arlo J Loutan, Egor P Tchesnokov, et al.
Journal of Bacteriology
|
September 15, 2005
Whole-genome sequence analysis of Pseudomonas syringae pv. phaseolicola 1448A reveals divergence among pathovars in genes involved in virulence and transposition
Vinita Joardar, Magdalen Lindeberg, Robert W Jackson, et al.
Nature Chemical Biology
|
September 29, 2022
Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infection
Chang-Ki Oh, Tomohiro Nakamura, Nathan Beutler, et al.
Oncogenesis
|
May 10, 2016
Association of p53 codon72 Arg>Pro polymorphism with susceptibility to nasopharyngeal carcinoma: evidence from a case-control study and meta-analysis
S K Sahu, S Chakrabarti, S D Roy, et al.
Nature Communications
|
February 8, 2024
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor
Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak, et al.
Biorxiv : the Preprint Server for Biology
|
April 12, 2022
Targeted protein S-nitrosylation of ACE2 as potential treatment to prevent spread of SARS-CoV-2 infection
Chang-Ki Oh, Tomohiro Nakamura, Nathan Beutler, et al.
ACS Medicinal Chemistry Letters
|
August 23, 2014
Lead optimization of imidazopyrazines: a new class of antimalarial with activity on Plasmodium liver stages
Bin Zou, Advait Nagle, Arnab K Chatterjee, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals
Laura Riva, Shuofeng Yuan, Xin Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2020
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer
Preeti Narayan, Tatiana M Prowell, Jennifer J Gao, et al.
Page
of 128